Bio Path reported $680K in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Baxter International USD 6.87B 61M Dec/2025
Bio Path USD 680K 1.44M Jun/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
CSL USD 11.85B 1000K Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Karyopharm Therapeutics USD 89.75M 8.12M Sep/2025